Nektar Therapeutics
NKTR
$41.17+0.91%
End of day · as of Oct 9, 2026, 8:02 PM ET
Mkt cap
$307.19M
EV/Sales
5.29
P/E ratio
N/A
FY2025 Revenue
$55.23M
EPS (TTM)
$-9.49
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-297.07%
Beta
0.56
Div yield
N/A
Sector
Healthcare
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported NKTR revenue for 2025-12-31 was $55.2M. Net income was -$164.1M. Revenue was down 43.9% from 2024-12-31 to 2025-12-31. NKTR currently screens at market cap $307.2M.
Use this NKTR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NKTR income, balance, and cash tables.
Nektar Therapeutics (NKTR) is a biotechnology company in the Healthcare sector.
Latest cached Nektar Therapeutics (NKTR) revenue for Dec 31, 2025 was $55.2M. Net income was -$164.1M. Statements: https://lician.com/financials/nktr
Nektar Therapeutics (NKTR) market capitalization is $307.2M on the latest cached snapshot.
Nektar Therapeutics (NKTR) cached previous close $40.80; day range $40.33 – $42.38; volume 1,087,103. Session quote: https://lician.com/quote/nktr
Nektar Therapeutics (NKTR) latest cached earnings event is "NKTR earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NKTR filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/nktr